Physician profile
John R Bach
NPI 1295749422
$3,931.88
in general payments reported to CMS, 2019-2025
10 companies · $445 in 2025
The $445 reported for 2025 was more than what 77% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,894 · 2021: $921 · 2022: $599 · 2023: $73.03 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.22 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,500.00 | 2019 | |
| Zoll Medical Corporation | $599.00 | 2022 | |
| Ns Pharma, INC. | $599.00 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $571.67 | 2019-2021 | |
| Catalyst Pharmaceuticals, INC. | $236.22 | 2025 | |
| Novartis Pharmaceuticals Corporation | $137.49 | 2025 | |
| Biogen, INC. | $128.99 | 2019-2023 | Spinraza |
| Novartis Gene Therapies, INC. (Fka Avexis, INC.) | $75.00 | 2021 | |
| 3b Medical, INC. | $71.48 | 2025 | Luna |
| Resmed Corp | $13.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.